Maleddu, A.; Pantaleo, MARIA ABBONDANZA; Castellucci, Paolo; Astorino, M.; Nanni, Cristina; Nannini, Margherita; Busato, F.; Di Battista, M.; Farsad, M.; Lodi, F.; Fanti, Stefano; Biasco, Guido; Boschi, S., 11C-acetate PET for early prediction of sunitinib response in metastatic renal cell carcinoma., «TUMORI», 2009, 95(3), pp. 382 - 384 [Scientific article]
G.GHIGI; R.MICERA; A.M.MAFFIONE; P.CASTELLUCCI; S.CAMMELLI; I. AMMENDOLIA; C. NANNI; E. BARBIERI; G.GRASSETTO; S.FANTI; D.RUBELLO, 11C-methionine vs. 18F-FDG PET in soft tissue sarcoma patients treated with neoadjuvant therapy: preliminary results, «IN VIVO», 2009, 23, pp. 105 - 110 [Scientific article]
Ambrosini V; Castellucci P; Rubello D; Nanni C; Musto A; Allegri V; Montini GC; Mattioli S; Grassetto G; Al-Nahhas A; Franchi R; Fanti S., 68Ga-DOTA-NOC: a new PET tracer for evaluating patients with bronchial carcinoid., «NUCLEAR MEDICINE COMMUNICATIONS», 2009, 30 (4), pp. 281 - 286 [Scientific article]
Ambrosini, V; Nanni, C; Zompatori, M; Castellucci, P; Allegri, V; Rubello, D; Montini, G; Grassetto, G; Lopci, E; Fantini, L; Franchi, R; Fanti, S, 68Ga-DOTA-NOC PET and CT retrospective analysis for neuroendocrine bone metastasis detection, in: European Journal of Nuclear Medicine and molecular Imaging. Abstracts Annual Congress of the EANM 2009, BERLIN, Springer, 2009, 36, suppl 2, pp. S202 - S202 (atti di: Annual Congress of the EANM, Barcelona, Spain, 9-14 Ottobre 2009) [Abstract]
Zinzani PL; Tani M; Fanti S; Stefoni V; Musuraca G; Castellucci P; Marchi E; Farsad M; Fina M; Pellegrini C; Alinari L; Derenzini E; de Vivo A; Bacci F; Pileri S; Baccarani M., A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients., «ANNALS OF ONCOLOGY», 2008, 19, pp. 769 - 773 [Scientific article]
Zinzani P.L.; Tani M.; Fanti S.; Stefoni V.; Musuraca G.; Vitolo U.; Perrotti A.; Fina M.; Derenzini E.; Baccarani M., A phase 2 trial of fludarabine and mitoxantrone chemoterapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma, «CANCER», 2008, 112(4), pp. 856 - 862 [Scientific article]
Rubello D.; Rampin L.; Banti E.; Grassetto G.; Massaro A.; Cittadin S.; Pavan L.; Cattelan A.M.; Fanti S.; Al-Nahhas A.; Gross M.D.; Alavi A., Antigranulocyte scintigraphy in infected hip prosthesis: the diagnostic importance of delayed 20-24-h imaging and semiquantitative analysis., «NUCLEAR MEDICINE COMMUNICATIONS», 2008, 29(11), pp. 994 - 998 [Scientific article]
Tsamita C.S.; Golemi A.; Egesta L.; Castellucci P.; Nanni C.; Stefoni V.; Grassetto G.; Rubello D.; Tani M.; Zinzani P.L.; Fanti S., Clinical significance of axillary findings in patients with lymphoma during follow-up with 18F-fluorodeoxyglucose-PET., «NUCLEAR MEDICINE COMMUNICATIONS», 2008, 29(8), pp. 705 - 710 [Scientific article]
A. Guido; P. Castellucci; F. Bunkheila; C. Fuccio; B. Rombi; C. Nanni; A. Cecconi; S. Fanti; E. Barbieri, Combined 18F-FDG-PET/CT imaging in radiotherapy target delineation for head-and-neck cancer, in: , «NUCLEAR MEDICINE», 2008, 49 suppl 1, pp. 357P - 357P [Abstract]
Ambrosini V.; Tomassetti P.; Castellucci P.; Campana D.; Montini G.; Rubello D.; Nanni C.; Rizzello A.; Franchi R.; Fanti S., Comparison between (68)Ga-DOTA-NOC and (18)F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours., «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2008, 35, pp. 1431 - 1438 [Scientific article]
Farace P.; Galiè M.; Nanni C.; Spinelli A.; Fanti S., Contouring carcinomas by FDG-PET: is the role of tumor biology underestimated? In regard to MacManus et al. (Int J Radiat Oncol Biol Phys 2008;71:2-4)., «INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS», 2008, 72, pp. 303 - 304 [Comment or similar]
Pantaleo M.A.; Nannini M.; Maleddu A.; Fanti S.; Ambrosini V.; Nanni C.; Boschi S.; Biasco G., Conventional and novel PET tracers for imaging in oncology in the era of molecular therapy.
Review, «CANCER TREATMENT REVIEWS», 2008, 34, pp. 103 - 121 [Scientific article]
Nanni C; Rubello D; Fanti S., Could choline PET play a role in malignancies other than prostate cancer?, «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2008, 35, pp. 216 - 218 [Comment or similar]
Magini G, Frigerio M, Farsad M, Serra C, Colecchia A, Jovine E, Vivarelli M, Feletti V, Golfieri R, Lodi F, Franchi R, Fanti S, Bernardi M, Trevisani F, Differential diagnosis between focal nodular hyperplasia and hepatocellular adenoma: Potential role of double tracer PET with 11C-Acetate and 18F-FDG, «JOURNAL OF HEPATOLOGY», 2008, 48, pp. 153 - 153 [Abstract]
Fanti S.; Castellucci P.; Stefoni V.; Nanni C.; Tani M.; Rubello D.; Ambrosini V.; Zinzani P.L.; Franchi R., Early relapse in a patient with Hodgkin's disease and negative interim FDG-PET., «ANNALS OF NUCLEAR MEDICINE», 2008, 22(5), pp. 429 - 432 [Scientific article]
